Shakti H Ramkissoon

Shakti H Ramkissoon

UNVERIFIED PROFILE

Are you Shakti H Ramkissoon?   Register this Author

Register author
Shakti H Ramkissoon

Shakti H Ramkissoon

Publications by authors named "Shakti H Ramkissoon"

Are you Shakti H Ramkissoon?   Register this Author

54Publications

2498Reads

15Profile Views

Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.

J Neurooncol 2019 Mar 9;142(1):111-118. Epub 2018 Dec 9.

Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-018-03070-2
Publisher Site
http://dx.doi.org/10.1007/s11060-018-03070-2DOI Listing
March 2019

Hypoxia-inducible factor 2α: a novel target in gliomas.

Future Med Chem 2018 09 9;10(18):2227-2236. Epub 2018 Aug 9.

Brain Tumor Center of Excellence, Wake Forest Comprehensive Cancer Center, Winston-Salem, NC 27157, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc-2018-0163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479274PMC
September 2018

Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.

Neuro Oncol 2017 Jul;19(7):986-996

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Department of Pathology, Department of Radiology, Department of Neurosurgery, Boston Children's Hospital, Boston, Massachusetts; Department of Medical Oncology, Oncologic Pathology, Department of Pediatric Oncology, Department of Cancer Biology, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Pathology, Department of Neurosurgery, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Pratiti Bandopadhayay, Broad Institute of MIT and Harvard, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570190PMC
July 2017

Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.

Neuro Oncol 2017 Jul;19(7):908-917

Department of Radiation Oncology, Department of Pathology, Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center (DF/BWCC), Harvard Medical School, Boston, Massachusetts; Department of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Accelerate Brain Cancer Cure (ABC2), Washington, DC; Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570228PMC
July 2017

Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors.

Endocrinology 2017 07;158(7):2284-2291

Center for Skull Base and Pituitary Surgery, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2016-1967DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505210PMC
July 2017

Genomic characterization of recurrent high-grade astroblastoma.

Cancer Genet 2016 Jul-Aug;209(7-8):321-30. Epub 2016 Jun 21.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Center for Molecular Oncologic Pathology, Dana Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2016.06.002DOI Listing
May 2017

Tyrosine receptor kinase B is a drug target in astrocytomas.

Neuro Oncol 2017 01 10;19(1):22-30. Epub 2016 Jul 10.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts (J.N., S.X., V.L., Y.S., P.B., R.B., T.M.R., C.D.S., R.A.S., J.J.Z.); Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts (J.N., S.X., V.L., T.M.R., J.J.Z.); Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (S.H.R., R.B., K.L.L., W.C.H.); Broad Institute, Boston, Massachusetts (P.B., R.B., W.C.H.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193024PMC
January 2017

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.

Neuro Oncol 2016 05 28;18(5):649-55. Epub 2016 Jan 28.

Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (M.A., P.H.M., R.B., M.L.L., S.H.R., R.D.F., K.L.L., A.H.L., S.S.); Department of Pathology, King Fahad Medical City, Riyadh, Saudi Arabia (M.A.); King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia (M.A.); Harvard Medical School, Boston, Massachusetts (M.A., A.A.A., D.D.-S., P.K.B., D.A.R., P.Y.W., O.A.-M., S.H.R., R.D.F., K.L.L., A.H.L., B.M.A., I.F.D., R.B., S.S.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (W.L.B., O.A.-M., I.F.D.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (A.A.A., B.M.A.); Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts (P.K.A.); Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts (D.D.-S.); Center for Cancer Genomic Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts (A.R.T., P.V.H.); Department of Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts (P.K.B.); Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (D.A.R., P.Y.W, R.B.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (K.L.L., R.B.); Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA (S.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827048PMC
May 2016

Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation.

World Neurosurg 2016 Jan 28;85:96-105. Epub 2015 Jul 28.

Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2015.07.032DOI Listing
January 2016

Adult Atypical Teratoid/Rhabdoid Tumors.

World Neurosurg 2016 Jan 4;85:197-204. Epub 2015 Sep 4.

Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2015.08.076DOI Listing
January 2016

Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma.

Diagn Pathol 2016 Jan 27;11:13. Epub 2016 Jan 27.

Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13000-016-0455-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729030PMC
January 2016

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.

Neuro Oncol 2015 Oct 9;17(10):1344-55. Epub 2015 Mar 9.

Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., S.H., D.K., Y.J.K., K.L.L.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.E.S., L.B., M.B., D.A.R., E.Q.L., M.L.R., A.D.N., L.N., S.R., L.M.D., D.C.L., P.K., B.J.R., P.Y.W., R.B., K.L.L.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (W.L.B., E.B.C, O.A.-M., M.D.J., A.J.G., I.F.D., E.A.C.); Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts (L.T.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (M.H., A.A.A., N.D.A., B.M.A.); Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (M.H., A.A.A., N.D.A., B.M.A.); Harvard Radiation Oncology Program, Boston, Massachusetts (A.R.); Kravis Center for Molecular Oncology & Department of Epidemiology and Biostatistics, Memorial Sloan- Kettering Cancer Center, New York, New York (N.S.); Broad Institute, Cambridge, Massachusetts (R.B.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., A.D., J.B.C., M.A., S.S., R.D.F., N.I.L., A.H.L., K.L.L.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578577PMC
October 2015

Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.

Neuro Oncol 2015 May 2;17(5):697-707. Epub 2014 Nov 2.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482855PMC
May 2015

SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance.

Nature 2015 Apr 8;520(7547):363-7. Epub 2015 Apr 8.

1] Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA [2] Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [3] The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA [4] Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA [5] Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533874PMC
April 2015

Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level.

Oncotarget 2015 Jan;6(2):1190-201

New Jersey Medical School, Rutgers, Newark, NJ, USA.Graduate School of Biomedical Science, Rutgers School of Biomedical Health Sciences, Newark, NJ, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359226PMC
http://dx.doi.org/10.18632/oncotarget.2778DOI Listing
January 2015

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.

Neuro Oncol 2014 Nov 2;16(11):1547-53. Epub 2014 Jun 2.

Harvard Radiation Oncology Program, Brigham and Women's Hospital, Boston, Massachusetts (A.A.A.); Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (N.D.A., B.M.A.); Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts (P.C.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (E.B.C., A.J.G., M.D.J., O.A-M., I.F.D.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (P.Y.W., D.A.R., E.Q.L., L.N., M.L.R., R.B.); Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania (S.E.W.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., S.S., M.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201070PMC
November 2014

Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.

J Neuropathol Exp Neurol 2014 Nov;73(11):994-8

From the Department of Pathology, Brigham and Women's Hospital (IHS, SHR, DAMJ, RDF); Harvard Medical School (IHS, SHR, DAMJ, RDF); and Boston Children's Hospital (SHR, RDF), Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NEN.0000000000000125DOI Listing
November 2014

Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery.

Proc Natl Acad Sci U S A 2014 Jul 30;111(30):11121-6. Epub 2014 Jun 30.

Department of Cancer Biology, Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA 02115;Neurosurgery, andRadiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1404724111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121790PMC
July 2014

Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity.

Mol Ther Nucleic Acids 2013 Oct 1;2:e126. Epub 2013 Oct 1.

1] Rutgers University-Graduate School of Biomedical Science, Newark, New Jersey, USA [2] New Jersey Medical School, Newark, New Jersey, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21622531163018
Publisher Site
http://dx.doi.org/10.1038/mtna.2013.60DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027430PMC
October 2013

Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy.

Sci Rep 2012 30;2:906. Epub 2012 Nov 30.

Department of Medicine - Division of Hematology/Oncology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey , Newark, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep00906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510468PMC
May 2013

An indirect role for oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells.

Exp Cell Res 2012 Dec 12;318(20):2604-15. Epub 2012 Sep 12.

UMDNJ-New Jersey Medical School, 185 South Orange Avenue, MSB E-585, Newark, NJ 07103, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2012.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645290PMC
December 2012

G-coupled protein receptors and breast cancer progression: potential drug targets.

Mini Rev Med Chem 2007 Mar;7(3):245-51

Graduate School of Biomedical Sciences, UMDNJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138955707780059826DOI Listing
March 2007

Nuclear factor-kappaB is central to the expression of truncated neurokinin-1 receptor in breast cancer: implication for breast cancer cell quiescence within bone marrow stroma.

Cancer Res 2007 Feb;67(4):1653-9

Department of Medicine and Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-3813DOI Listing
February 2007

Hematopoietic-specific microRNA expression in human cells.

Leuk Res 2006 May 12;30(5):643-7. Epub 2005 Oct 12.

Howard Hughes Medical Institute-National Institutes of Health Research Scholars Program, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S0145212605003565/1-s2.0-S014521260500
Web Search
http://dx.doi.org/10.1016/j.leukres.2005.09.001DOI Listing
May 2006

Nonisotopic detection of microRNA using digoxigenin labeled RNA probes.

Mol Cell Probes 2006 Feb;20(1):1-4

Howard Hughes Medical Institute-National Institutes of Health Research Scholars Program, Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcp.2005.07.004DOI Listing
February 2006

G protein-coupled receptors in haematopoietic disruption.

Expert Opin Biol Ther 2006 Feb;6(2):109-20

Department of Medicine-Hematology/Oncology, New Jersey Medical School, University of Medicine & Dentistry of New Jersey, Newark, NJ 07103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.6.2.109DOI Listing
February 2006

Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides.

Proc Natl Acad Sci U S A 2005 Nov 16;102(48):17436-41. Epub 2005 Nov 16.

Department of Medicine and Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0506351102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297665PMC
November 2005

Autocrine proliferation of neuroblastoma cells is partly mediated through neurokinin receptors: relevance to bone marrow metastasis.

J Neurooncol 2005 Jan;71(2):91-8

New Jersey Medical School (UMDNJ-NJMS), Department of Medicine - Hematology/Oncology, University of Medicine and Dentistry of New Jersey, 185 South Orange Avenue, MSB, Room E-579, Newark, NJ 07103, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-004-9182-2
Publisher Site
http://dx.doi.org/10.1007/s11060-004-9182-2DOI Listing
January 2005

Defect in the lymphoid compartment might account for CD8+-mediated effects in the pathophysiology of pure red cell aplasia.

Clin Immunol 2003 Sep;108(3):248-56

UMDNJ-New Jersey Medical School, Department of Medicine-Hematology, Newark, NJ 07103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1521-6616(03)00139-6DOI Listing
September 2003